Lilly have entered into a worldwide licensing agreement with Australian-based Acrux for Axiron, an experimental under-arm testosterone applicator.The treatment is …
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand

